RHON-KLINIKUM AG Unsponsored ADR
RKAGY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $2 | $1 | $1 | $2 |
| % Growth | 9% | 1.2% | -9.1% | – |
| Gross Profit | $0 | $0 | $1 | $0 |
| % Margin | 10.8% | 10.2% | 69.1% | 11.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 7.7% | 8% | 6.8% | 6.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 2.7% | 2.6% | 1.7% | 1.8% |
| EPS Diluted | 0.34 | 0.29 | 0.19 | 0.21 |
| % Growth | 17.2% | 52.6% | -9.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |